Hims stock surged Wednesday, topping a buy point, after the telehealth behemoth announced a menopause care program.
Cameco stock is breaking out past its latest buy point, with the relative strength line at a new high, a bullish indicator.
Innovator IBD 50 ETF (FFTY) is outperforming major indexes in 2024. See here for an analysis of its risks, and whether this ...